FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Afrezza (insulin human) from MannKind Corporation. This approval updates the label/indication for the inhaled in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

SUPPL AP for AFREZZA (INSULIN HUMAN)